zhejiang shengda bio-pharm (603079.SH) issued an announcement, recently received a notice from the Shanghai Stock Exchange Listing Review Center...
According to the announcement by Financial Associated Press, zhejiang shengda bio-pharm (603079.SH) recently received a notice from the Shanghai Stock Exchange Listing Review Center regarding the approval of the issuance of stocks to specific entities. Based on the review results, the company's application to issue stocks to specific entities complies with the issuance conditions, listing conditions, and information disclosure requirements.